Since transplantation of pancreatic islet cells can normalize metabolic control in a way that has been virtually impossible to achieve with exogenous insulin, it is being explored, in a selected cohort of patients, as an experimental T1D therapy [1,2]. Here, INS is linked to type 1 diabetes mellitus.